Literature DB >> 12559937

Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Frans Van de Werf1, Diego Ardissino, Amadeo Betriu, Dennis V Cokkinos, Erling Falk, Keith A A Fox, Desmond Julian, Maria Lengyel, Franz-Josef Neumann, Witold Ruzyllo, Christian Thygesen, S Richard Underwood, Alec Vahanian, Freek W A Verheugt, William Wijns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12559937     DOI： 10.1016/s0195-668x(02)00618-8

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  212 in total

Review 1.  Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.

Authors:  Paul W Armstrong; Robert C Welsh
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

Review 2.  Management of acute coronary syndromes: an update.

Authors:  Keith A A Fox
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

3.  Practising what is preached: the MINAP study.

Authors:  O C Raffel; H D White
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 4.  Adjunctive treatment in patients treated with thrombolytic therapy.

Authors:  M A Brouwer; N Clappers; F W A Verheugt
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

5.  [Cardiovascular prevention and rehabilitation].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2003-12-20       Impact factor: 0.743

6.  Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial.

Authors:  A Ghani; J-H E Dambrink; A W J van 't Hof; J P Ottervanger; A T M Gosselink; J C A Hoorntje
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

7.  Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.

Authors:  Morten L Hansen; Gunnar H Gislason; Lars Køber; Tina Ken Schramm; Fredrik Folke; Pernille Buch; Steen Z Abildstrom; Mette Madsen; Søren Rasmussen; Christian Torp-Pedersen
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

8.  The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.

Authors:  Christopher J Boos; Balu Balakrishnan; Gregory Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2007-06-16       Impact factor: 2.300

Review 9.  Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

10.  Is nighttime blood pressure important in cardiovascular risk assessment in coronary atherosclerosis?

Authors:  W Sobiczewski; M Wirtwein; M Gruchala
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.